Therapix Biosciences Ltd

Sponsored ADR (1 ADS : 20 Ordinary) International Reporting
Verified Company Profile 9/19/2016
Contact Info
  • 5 Azrieli Center (Square Tower
  • 27 floor
  • Tel-Aviv 6702501
  • Israel

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: Tel Aviv Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Quarterly Report
CIK 0001611746
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Business Status Development Stage Company a/o Aug 18, 2014
Incorporated In: Israel
Year of Inc. 2004
Employees 5 a/o Sep 18, 2016
Company Officers/Contacts
Elran Haber CEO, VP, Business Development
Guy Goldin CFO
Doron Ben Ami Chief Strategy Officer
Company Directors
Ascher Shmuelwitz Chairman
Amit Berger
Zoar Heiblum
Micha Jesselson
Avi Meizler
Yafit Stark
Service Providers
Accounting/Auditing Firm
E&Y Israel
2 Pal Yam
Haifa, 3309502

Legal Counsel
Horn & Co. Law Offices
Amot Investments Tower
2 Weizmann St.
24th Floor
Tel Aviv, 6423902

Investor Relations Firm
The Ruth Group
757 Third Avenue
22nd Floor
New York, NY, 10017
United States

Cooper Global Communications
40 East 78th Street
Suite 8-C
New York, NY, 10075
United States

THXBY Security Details
Share Structure
Market Value1 $8,220,193 a/o Oct 21, 2016
Authorized Shares Not Available
Outstanding Shares 40,998,471 a/o Sep 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 26,865,234 a/o Sep 18, 2016
Par Value Not Available
Transfer Agent(s)
BNY Mellon
Shareholders of Record Not Available
Non US Stock Exchange Listing
TRPX - Tel Aviv Stock Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security